Abstract
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of the hematopoietic stem cell that is exceptionally rare in the first five years of life, particularly as a secondary malignancy. This report describes a case of secondary CML in a four-year-old female occurring after AML treatment. Interestingly, CML developed while on immunosuppression for a heart transplant due to anthracycline-induced cardiomyopathy.
Original language | English (US) |
---|---|
Pages (from-to) | 166-168 |
Number of pages | 3 |
Journal | Pediatric Blood and Cancer |
Volume | 62 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2015 |
Keywords
- AML
- CML
- Heart transplant
- Secondary malignancy
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Hematology
- Oncology